Nanotechnology Now - Press Release: Acrylamide exposure impairs blood-cerebrospinal fluid barrier function

Home > Press > Acrylamide exposure impairs blood-cerebrospinal fluid barrier function

Abstract:
The blood-brain barrier prevents xenobiotics from entering the central nervous system. Growing evidence indicates that neurotoxins, such as tributyltin, manganese and nanoparticles, may disrupt the function of the blood-brain and blood-cerebrospinal fluid (CSF) barriers.

Acrylamide exposure impairs blood-cerebrospinal fluid barrier function

Shenyang, PR China | Posted on May 19th, 2014

Previous studies show that chronic acrylamide exposure leads to central and peripheral neuropathy. However, very few studies have focused on the effects of acrylamide exposure on these barriers. Prof. Yanshu Zhang and co-workers from Hebei United University in China found that acrylamide exposure damages the blood-cerebrospinal fluid barrier and impairs secretory and transport functions. These changes may underlie acrylamide-induced neurotoxicity. The research achievements have been published in the Neural Regeneration Research (Vol. 9, No. 5, 2014).

###

Article: " Acrylamide exposure impairs blood-cerebrospinal fuid barrier function," by Xue Yao1, Licheng Yan1, Lin Yao2, Weijun Guan3, Fanxu Zeng1, Fuyuan Cao2, Yanshu Zhang1 (1 College of Public Health, Hebei United University, Tangshan, Hebei Province, China; 2 Experimental Animal Center, Hebei United University, Tangshan, Hebei Province, China; 3 Key Laboratory of Hebei Health and Safety on Coal Industry, Hebei United University, Tangshan, Hebei Province, China)

Yao X, Yan LC, Yao L, Guan WJ, Zeng FX, Cao FY, Zhang YS. Acrylamide exposure impairs blood-cerebrospinal fluid barrier function. Neural Regen Res. 2014;9(5):555-560

####

For more information, please click here

Contacts:
Meng Zhao

86-138-049-98773

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: